Myocardial Infarction Statistics: Rates & Trends

Gain a statistical understanding of myocardial infarction’s global impact, evolving patterns, and outcomes. Essential data for public health insight.

Heart attack death rates in the United States and other high-income countries have fallen substantially over the past several decades, yet the global burden of myocardial infarction remains enormous and the decline has not been shared equally. A systematic review and meta-analysis estimated the global prevalence of prior heart attack at roughly 4% in people under 60 and about 10% in those over 60, with wide variation by region and income level. Behind these averages are diverging trends by age, sex, race, geography, and income that complicate any single narrative of progress.

The Long Decline in Mortality and Its Recent Interruption

In the U.S., the age-adjusted mortality rate for heart attacks among adults with hypertension fell from about 20 per 100,000 in 2000 to around 16 per 100,000 by 2023. But the decline was not a straight line. Mortality dropped steadily for most of that period, then reversed sharply between 2018 and 2021, coinciding with the COVID-19 pandemic. A similar pattern appeared among younger adults: between 2003 and 2018, heart attack death rates among people aged 25 to 44 fell by several percent per year, but from 2018 to 2020 those rates jumped by roughly 7% annually.

The pandemic disruption likely reflects several overlapping forces: delayed or avoided emergency care, higher stress and reduced physical activity, and worsening metabolic health. Whether this post-2018 uptick is a temporary blip or the start of a longer reversal remains an open question, and ongoing surveillance data will be critical.

Globally, the picture is bleaker in poorer countries. As of 2001, roughly three-quarters of all coronary heart disease deaths worldwide occurred in low- and middle-income nations, where access to acute cardiac care and long-term prevention is far more limited. Those figures have only grown since, driven by urbanization, dietary shifts, and rising rates of diabetes and obesity in regions that lack the catheterization labs and emergency networks that wealthier countries rely on.

Who Has Heart Attacks and When

Heart attacks are not primarily a disease of old age in the way many people assume. While the risk rises steeply with age, a striking share of first events occur in relatively young people. In one registry from the Gulf region, about a quarter of all first heart attacks occurred in patients classified as young, and those younger patients were far more likely to be male, current smokers, and obese compared with older patients. In a U.S. registry specifically studying people who had a heart attack at age 50 or younger, even the very youngest patients (age 40 and under) had high rates of traditional risk factors like high cholesterol, diabetes, and family history. The main difference was that the very youngest group had notably higher rates of substance abuse.

Sex differences are substantial and persistent. Men have higher heart attack rates than women across virtually every population studied. In the Netherlands, the overall sex disparity was about twofold, but among certain ethnic minority groups the gap was far wider: men of Turkish, South Asian, and Moroccan descent had roughly three to four times the heart attack risk of women from the same background, and these differences were most pronounced below age 55. Beyond incidence, gender disparities also shape presentation, management, and outcomes. Women are more likely to have atypical symptoms, to be undertreated, and to experience worse in-hospital outcomes.

The Nine Risk Factors That Account for Almost Everything

The INTERHEART study, one of the largest case-control studies ever conducted on heart attack risk, recruited participants from 52 countries and arrived at a finding that still anchors the field: nine modifiable risk factors collectively explain over 90% of the risk of a first heart attack in both men and women, and across all age groups and world regions. Smoking roughly tripled the odds. Abnormal blood lipids, high blood pressure, diabetes, abdominal obesity, psychosocial stress, lack of daily fruit and vegetable intake, physical inactivity, and absence of moderate alcohol use each independently contributed. Further analysis of the same dataset showed that the associations were generally stronger in younger individuals, meaning these risk factors hit hardest when people think they are too young to worry about heart disease.

Independent validation has come from other populations. In Costa Rica, for example, abdominal obesity, smoking, inactivity, and poor diet were the top contributors to heart attack risk in a pattern closely resembling the INTERHEART findings. The consistency across regions is both reassuring and challenging. Reassuring because the same levers work everywhere. Challenging because the rising global prevalence of obesity, diabetes, and sedentary lifestyles means these same levers are being pushed in the wrong direction in much of the world.

STEMI Versus NSTEMI Trends

Heart attacks come in two broad types, distinguished by what shows up on the initial electrocardiogram. STEMI, the type with full-thickness heart muscle damage visible immediately on the ECG, is the one most people picture when they think of a heart attack. NSTEMI involves partial or subtler damage and tends to occur in older patients with more chronic underlying disease. Over the past two decades, these two types have moved in opposite directions. Between 1997 and 2005 in the U.S., STEMI rates dropped from about 121 to 77 per 100,000, while NSTEMI rates crept up slightly from 126 to 132 per 100,000. More recent Canadian data through 2021 confirmed the same pattern: a 15% drop in STEMI incidence alongside an 11% rise in NSTEMI.

Part of this shift is real: better control of cholesterol and blood pressure may preferentially prevent the explosive plaque ruptures that cause STEMI. Part is diagnostic: more sensitive blood tests for heart damage (high-sensitivity troponin assays) now detect smaller heart attacks that would previously have been missed, and most of those are NSTEMI.

The mortality implications are nuanced. In the short term, STEMI is more lethal. One Korean registry found that in-hospital death in the first week was about 5% for STEMI versus under 2% for NSTEMI. But the gap flipped within two weeks: from the second week onward, NSTEMI patients actually had higher mortality rates. A European study found similar convergence: at 28 days STEMI patients were worse off, but by 10 years there was no meaningful difference in survival between the two types. NSTEMI patients tend to be older and sicker at baseline, which catches up with them over time.

Racial, Ethnic, and Socioeconomic Disparities

Some of the starkest patterns in heart attack statistics have nothing to do with biology and everything to do with where you live and what you earn. In the U.S., heart attack mortality rates are persistently higher among Black individuals, in Southern states, and in rural areas. Non-white patients continue to receive less guideline-consistent care and have higher rates of complications.

Some of this gap is created inside the hospital itself. A landmark study of U.S. hospitals found that the time from arrival to receiving clot-busting medication or balloon angioplasty was significantly longer for Black, Hispanic, and Asian patients than for white patients. Black patients waited an average of about 41 minutes for clot-busting drugs compared with roughly 34 minutes for white patients. For balloon procedures, Black patients waited about 122 minutes versus 103 for white patients. These differences shrank once researchers accounted for which hospitals different groups tended to use, but significant gaps persisted even after adjusting for insurance, clinical severity, and hospital characteristics.

Income matters independently of race. A six-country study found that higher-income patients had 30-day mortality that was one to three percentage points lower than lower-income patients, and one-year survival gaps were even wider. In Israel, high-income patients with STEMI had a one-year mortality of about 16%, versus 25% for low-income patients. Higher-income individuals were more likely to receive lifesaving procedures, had shorter hospital stays, and fewer readmissions, and this held true even in countries with universal health insurance. In Sweden, which has one of the most egalitarian healthcare systems in the world, the socioeconomic gap in heart attack incidence remained stable across more than two decades of observation. The problem is deeply embedded: income, education, employment status, and neighborhood factors all independently affect cardiovascular outcomes.

How Treatment Speed Shapes Survival

For STEMI, the interval between arriving at the hospital and having the blocked artery opened with a balloon catheter is one of the strongest modifiable predictors of whether you survive. Each hour of delay in this “door-to-balloon” time was associated with a 55% increase in the odds of dying within a year. Getting the time below 45 minutes cut the risk of death to less than a third of what it was when the time exceeded 90 minutes. Every 30-minute reduction continued to yield a meaningful survival benefit, even below the 60- to 90-minute threshold that guidelines have traditionally targeted.

Prehospital systems play a key role in compressing these times. When emergency medical teams perform an ECG in the ambulance and transmit it to the hospital ahead of arrival, the receiving team can have the catheterization lab ready before the patient comes through the door. The widespread adoption of such systems across the U.S. and Europe is one of the main reasons in-hospital mortality from STEMI has dropped so much over the past two decades.

That said, recent evidence suggests the relationship between door-to-balloon time and outcomes is more complex than a simple “faster is always better.” A large study found that in patients who were not in cardiogenic shock, door-to-balloon times had less independent impact on outcomes once other clinical factors were accounted for. Among patients in the sickest category (cardiogenic shock), exceeding 90 minutes clearly worsened outcomes, but there was no detectable difference between reaching the goal in under 60 minutes versus 61 to 90 minutes. This does not undermine the urgency of fast treatment, but it does suggest that once systems are performing well, further gains may come from optimizing other parts of care rather than shaving minutes off an already fast process.

Life After a Heart Attack

Surviving a heart attack is not the end of the story. One of the most important trends in cardiac care is that more people survive their initial event but face significant long-term complications, particularly heart failure. Data spanning several decades showed that the 30-day incidence of heart failure after a heart attack more than doubled, from about 10% in the 1970s to 23% in the 1990s, even as 30-day mortality from the heart attack itself dropped from 12% to 4%. People who once would have died in the acute phase now survive with damaged hearts. In a more recent study of older U.S. adults, roughly one in three developed heart failure within a year of their heart attack.

Recurrence is another major concern. About 2.5% of heart attack patients are readmitted with another heart attack within 90 days of discharge. While that number sounds low, the consequences are severe: nearly half of those who had an early recurrence died within five years, compared to about 22% of those who did not. The most common causes of early recurrence were stent-related clotting and progression of existing artery disease. In longer-term follow-up from a European cohort, about half of patients who had a heart attack never experienced a recurrent cardiovascular event, while roughly a third had another cardiac event and about 9% had a stroke.

Silent Heart Attacks and MINOCA

Not all heart attacks announce themselves with chest pain and a dramatic ambulance ride. Silent heart attacks, discovered incidentally on a later ECG or imaging study, are surprisingly common. In a large U.S. study, people with a silent heart attack on their record had about a 35% higher risk of developing heart failure compared with people who had never had any kind of heart attack. Among patients undergoing major vascular surgery, roughly one in four had evidence of an unrecognized prior heart attack, and those patients had nearly double the risk of dying during follow-up.

Another atypical category getting more attention is MINOCA, or heart attack with non-obstructive coronary arteries. Up to 15% of all heart attacks occur without the severe artery blockages that define the classic scenario. MINOCA disproportionately affects women and tends to strike at younger ages with fewer traditional risk factors. Despite this seemingly milder profile, the long-term outlook for MINOCA patients is no better than for those with traditional blocked-artery heart attacks. One challenge is that MINOCA has many possible underlying causes, from coronary artery spasm to spontaneous dissection to small-vessel disease, and identifying the right one often requires advanced imaging beyond a standard angiogram. A recent study showed that patients who received a more thorough diagnostic workup were significantly more likely to have their underlying cause identified and their treatment changed accordingly.

Environmental Triggers

Heart attacks do not just reflect chronic risk factors. Short-term environmental exposures can trigger acute events in vulnerable people. An international study covering 27 countries found that both heat waves and cold spells increased the odds of heart attack death. Heat waves had a stronger effect, with odds ratios ranging from about 1.18 to 1.74 depending on intensity and duration. When heat waves occurred alongside elevated fine particulate air pollution, the combined effect was greater than either alone.

More granular analysis from a cold-climate region found that different types of heart attacks responded differently to environmental stress. STEMI risk spiked with acute exposures to extreme cold or heat and to short-term rises in fine particulate matter. NSTEMI responded more to sustained heat and to delayed effects of nitrogen dioxide pollution. Atmospheric pressure, snow depth, sunshine duration, and ultraviolet intensity all showed non-linear associations with risk. As climate change increases the frequency and severity of temperature extremes, these environmental triggers may become a larger factor in heart attack trends.

The Economic Burden

The financial toll of heart attacks extends far beyond the hospital bill. In the U.S., the total annual cost of heart attacks between 2003 and 2014 was estimated at about $85 billion in 2016 dollars. Only about $30 billion of that was direct medical spending; the remaining $55 billion came from lost productivity due to disability and premature death. For individual patients, healthcare costs roughly double in the year following a heart attack compared with the year before, and while they decline afterward, they remain elevated for at least a decade.

Survival After Out-of-Hospital Cardiac Arrest

Many heart-attack-related deaths happen before the patient ever reaches a hospital, during out-of-hospital cardiac arrest. Survival from these events has improved, though it remains low. Adjusted survival rates in the U.S. rose from about 5.7% in 2005–2006 to about 8.3% in 2012. The gains were partly attributable to modest increases in bystander CPR and public use of automated external defibrillators. Those numbers underline a hard reality: the single most important determinant of surviving a cardiac arrest is whether someone nearby starts CPR immediately and whether a defibrillator is within reach. All the advances in catheterization labs and drug therapy are irrelevant if the patient never makes it to the hospital alive.